Tenet Healthcare Statistics
Total Valuation
THC has a market cap or net worth of $18.15 billion. The enterprise value is $28.36 billion.
| Market Cap | 18.15B |
| Enterprise Value | 28.36B |
Important Dates
The last earnings date was Tuesday, October 28, 2025, before market open.
| Earnings Date | Oct 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
THC has 87.89 million shares outstanding. The number of shares has decreased by -7.08% in one year.
| Current Share Class | 87.89M |
| Shares Outstanding | 87.89M |
| Shares Change (YoY) | -7.08% |
| Shares Change (QoQ) | -3.47% |
| Owned by Insiders (%) | 0.72% |
| Owned by Institutions (%) | 99.47% |
| Float | 87.11M |
Valuation Ratios
The trailing PE ratio is 14.17 and the forward PE ratio is 12.68. THC's PEG ratio is 0.83.
| PE Ratio | 14.17 |
| Forward PE | 12.68 |
| PS Ratio | 0.91 |
| Forward PS | 0.83 |
| PB Ratio | 4.52 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 12.08 |
| P/OCF Ratio | 7.32 |
| PEG Ratio | 0.83 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.34, with an EV/FCF ratio of 18.88.
| EV / Earnings | 20.94 |
| EV / Sales | 1.36 |
| EV / EBITDA | 6.34 |
| EV / EBIT | 7.78 |
| EV / FCF | 18.88 |
Financial Position
The company has a current ratio of 1.71, with a Debt / Equity ratio of 1.52.
| Current Ratio | 1.71 |
| Quick Ratio | 1.48 |
| Debt / Equity | 1.52 |
| Debt / EBITDA | 2.70 |
| Debt / FCF | 8.78 |
| Interest Coverage | 4.45 |
Financial Efficiency
Return on equity (ROE) is 27.36% and return on invested capital (ROIC) is 10.64%.
| Return on Equity (ROE) | 27.36% |
| Return on Assets (ROA) | 7.75% |
| Return on Invested Capital (ROIC) | 10.64% |
| Return on Capital Employed (ROCE) | 14.67% |
| Revenue Per Employee | $212,714 |
| Profits Per Employee | $13,816 |
| Employee Count | 98,000 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 35.00 |
Taxes
In the past 12 months, THC has paid $479.00 million in taxes.
| Income Tax | 479.00M |
| Effective Tax Rate | 17.27% |
Stock Price Statistics
The stock price has increased by +31.04% in the last 52 weeks. The beta is 1.52, so THC's price volatility has been higher than the market average.
| Beta (5Y) | 1.52 |
| 52-Week Price Change | +31.04% |
| 50-Day Moving Average | 195.86 |
| 200-Day Moving Average | 160.48 |
| Relative Strength Index (RSI) | 56.73 |
| Average Volume (20 Days) | 1,053,203 |
Short Selling Information
The latest short interest is 2.55 million, so 2.90% of the outstanding shares have been sold short.
| Short Interest | 2.55M |
| Short Previous Month | 2.52M |
| Short % of Shares Out | 2.90% |
| Short % of Float | 2.92% |
| Short Ratio (days to cover) | 2.38 |
Income Statement
In the last 12 months, THC had revenue of $20.85 billion and earned $1.35 billion in profits. Earnings per share was $14.57.
| Revenue | 20.85B |
| Gross Profit | 8.56B |
| Operating Income | 3.65B |
| Pretax Income | 2.77B |
| Net Income | 1.35B |
| EBITDA | 4.47B |
| EBIT | 3.65B |
| Earnings Per Share (EPS) | $14.57 |
Balance Sheet
The company has $2.98 billion in cash and $13.19 billion in debt, giving a net cash position of -$10.21 billion or -$116.20 per share.
| Cash & Cash Equivalents | 2.98B |
| Total Debt | 13.19B |
| Net Cash | -10.21B |
| Net Cash Per Share | -$116.20 |
| Equity (Book Value) | 8.70B |
| Book Value Per Share | 45.68 |
| Working Capital | 3.25B |
Cash Flow
In the last 12 months, operating cash flow was $2.48 billion and capital expenditures -$976.00 million, giving a free cash flow of $1.50 billion.
| Operating Cash Flow | 2.48B |
| Capital Expenditures | -976.00M |
| Free Cash Flow | 1.50B |
| FCF Per Share | $17.09 |
Margins
Gross margin is 41.07%, with operating and profit margins of 17.49% and 6.50%.
| Gross Margin | 41.07% |
| Operating Margin | 17.49% |
| Pretax Margin | 13.31% |
| Profit Margin | 6.50% |
| EBITDA Margin | 21.45% |
| EBIT Margin | 17.49% |
| FCF Margin | 7.21% |
Dividends & Yields
THC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.08% |
| Shareholder Yield | 7.08% |
| Earnings Yield | 7.46% |
| FCF Yield | 8.28% |
Analyst Forecast
The average price target for THC is $215.94, which is 4.58% higher than the current price. The consensus rating is "Buy".
| Price Target | $215.94 |
| Price Target Difference | 4.58% |
| Analyst Consensus | Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (5Y) | 3.50% |
| EPS Growth Forecast (5Y) | -8.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 11, 2012. It was a reverse split with a ratio of 1:4.
| Last Split Date | Oct 11, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
THC has an Altman Z-Score of 1.85 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.85 |
| Piotroski F-Score | 6 |